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Abstract
The thymus serves as the primary lymphoid organ responsible for the development and
selection of a self-tolerant T cell repertoire. In paradox to its critical functions for the adaptive
immune response, the thymus undergoes a profound age associated decline beginning in early
adult life resulting in a significant decline in T cell function. Thymic epithelial cells (TECs) are a
critical component of the thymic microenvironment and undergo rapid turn-over, so
understanding the cellular mechanisms responsible for the maintenance of TEC number and
organization will be critical in counteracting age associated involution, particularly in cancer
patients, due to enhanced degeneration in response to therapy. In the search for stem/progenitor
populations that contribute to TEC maintenance in the postnatal thymus, our lab has identified a
new population of TEC progenitors that co-express the hematopoietic marker CD45 and the
definitive thymic epithelial marker EpCAM, which is also highly enriched in stem cell markers
such as, Sca1. CD45+ EpCAM+ cells are present in both the thymus and bone marrow (BM),
suggesting that the CD45+EpCAM+ population may be recruited from a hematopoietic derived
population in the BM, providing an additional source of progenitor cells that contribute to the
maintenance of the thymic stroma. Immunofluorescence microscopy of FACS sorted CD45+
EpCAM+ cells from thymus and bone marrow confirmed surface protein expression of both
markers, while Q-rtPCR confirmed co-expression of both genes at the RNA level. CD45+
EpCAM+ cells sorted from the BM or thymus of H2BGFP-expressing mice could contribute to
fetal reaggregate thymus organ cultures and differentiate into keratin-expressing TECs and FSP1 expressing fibroblasts after transplant under the kidney capsule of nude mice. Thus, BM
derived CD45+EpCAM+ cells represent a potential new source of cells that may contribute to
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thymic homeostasis. When an intact fetal C57BL6 thymus was placed into the kidney capsule of
an Actin H2BGFP mouse, H2BGFP-exressing cells homed to the fetal thymus and contributed to
both Keratin+ and FoxN1+ TECs as well as FSP1+ thymic fibroblasts. Significantly, when
Actin-H2BGFP fetal thymi were transplanted under the kidney capsule of a Rosa 26 mRFP
transgenic mouse and allowed to grow for three weeks RFP-expressing CD45+EpCAM+ and
CD45-EpCAM+ TECs were found to be present in the fetal thymus and were GFP-, indicating
that the cells were not derived from cell fusion but represented cells that migrated in from the
periphery of the Rosa26 mRFP mouse and differentiated into EpCAM expressing TECs. Very
few cells were found to express both GFP and mRFP. Future studies will characterize the
contribution of BM derived CD45+EpCAM+ stromal progenitors to distinct TEC
microenvironments in both the steady state thymus and under conditions of demand, as well as
their capacity to influence T cell selection and self-tolerance.
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Introduction
The thymus is a primary lymphoid organ formed from the endoderm of the third
pharyngeal pouch and is the exclusive site of T-cell development and selection in vertebrates [1,
2]. It contains various cell types, which can be divided broadly into the stromal and
hematopoietic compartments. The stromal compartment, non-migratory cells, of the thymus
contains the specialized epithelial cells called thymic epithelial cells (TECs), fibroblasts, nonfibroblast mesenchymal cells and thymic dendritic cells [3]. The hematopoietic compartment
contains the T-cells, their precursors, dendritic cells, macrophages as well as thymic B-cells as
well as other cells that originate from the bone marrow. The main function of this organ is to
generate self-restricted and self-tolerant T-cells in order to mount an appropriate adaptive
immune response [4]. One integral aspect of T-cell development is known as crosstalk, the
interaction of the stromal and non-stromal compartments of the thymus, which is critical to the
proper regulation and function of the thymus [5]. Generally, the TECs will interact with the
developing thymocytes in order to aid in their development and also to ensure that they have a
TCR (T-cell antigen receptor) that is tolerant to self. TECs are characterized by surface
expression of the epithelial cell adhesion molecule (EpCAM), a characteristic of all epithelium,
and the presence of keratin fibers in their cytoplasm. TECs can be separated into cortical TECs
(cTECs) and medullary TECs (mTECs) [6]. cTECs, defined as UEA1- (Ulex Europaeus
Agglutinin Type 1), DEC205+ (CD205, a scavenger receptor), CD45- (a panhematopoietic
receptor), are the site of positive selection of thymocytes with functioning T-cell receptors [7].
mTECs, defined as UEA1+ DEC205- CD45-, play a role in autoimmune regulation by
eliminating T-cells that have a high affinity for the self MHC (major histocompatibility complex)
molecule, which contain self-peptides expressed on the TEC during negative selection [8].
1

The thymus is thought to have progenitor populations for both the cortical and medullary
TECs in both the post and prenatal thymus. In the embryonic thymus, there is thought to be a
bipotent TEC progenitor that is defined by the expression of the scavenger receptor DEC205.
Baik et al. have shown that DEC205+ cells can give rise to both lineages of TECs [9].
Specifically, the DEC205+ progenitors can give rise to mTECs that express the AIRE protein
[9]. AIRE (autoimmune regulatory element), a nuclear protein, along with Fezf2 (forebrain
embryonic zinc-finger like protein 2) are thought to promote promiscuous gene expression
(PGE), the mechanism critical to promoting self-tolerance in T-cells [8, 10]. AIRE+ and Fezf2+
mTECs express self-peptides in their MHC molecules enabling T-cells expressing T cell antigen
receptors with a high affinity to self to be deleted in a process called negative selection;
ultimately if the T-cell makes a high affinity bond to a self-peptide the T-cell undergoes
apoptosis [8, 10].

T-cell development
The thymus is the exclusive site of T-cell development. T-cell progenitors enter the
thymus through the vasculature at the cortico-medullary junction (CMJ) from the bone marrow.
Developing thymocytes are identified by their expression of CD3, CD4, CD8, CD25 and CD44.
The earliest thymocytes express neither CD4 nor CD8 and they are identified as double negative
(DN) cells. These DN cells are classified based on the expression of CD25 and CD44: DN1
(CD44+ CD25-), DN2 (CD44+ CD25+), DN3 (CD44- CD25+) and finally DN4 (CD44-CD25-).
During DN progression T cell progenitors undergo VDJ recombination to allow expression of a
T-cell antigen receptor (TCR). After beginning to express the TCR, T-cell progenitors progress
to the double positive (DP) stage where they express both CD8 and CD4. Next, these cells will
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go on to express either CD4 or CD8, but not both, where they are called single positive cells.
From there the cells will go into the periphery and will attempt to eliminate potential pathogens
[4, 11, 12].
Once the lymphocyte progenitor cells enter the thymus they are known as early thymic
progenitors (ETPs) also known as DN1 cells. These DN1 cells will receive Notch signals from
cTECs to initiate commitment to the T-cell fate, at which point they will become DN2 cells.
Here the ETPs lose the potential to become myeloid and B fated cells [13]. These DN2 cells will
then rearrange either the β or γ chain of their TCR through the action of RAG 1 and 2 [14, 15].
Then, they will transition to the DN3 stage where they are fully committed to the T-cell fate [13].
The β-chain, once fully rearranged will then attempt to form a pre-TCR complex with an
invariant α chain. If successful, the cell will continue in development. However if this is
unsuccessful the cell will undergo apoptosis (β-selection) [13]. Furthermore, formation of the
pre-TCR complex by β-chain rearrangement will cease and the γ-chain will be silenced or vice
versa if the γ-chain is rearranged first [14]. Upon successful signaling from the pre-TCR
complex and Notch signals [16, 17], the cell will proliferate and upregulate CD4 and CD8
expression and become a DP cell.
At the double positive stage, the T-cell will rearrange the α-chain of the TCR and test the
TCR against self-protein self-MHC complexes expressed on cTECs. Failure of the DP
thymocytes to recognize MHC leads to death by neglect while binding leads to positive
selection, resulting in an upregulation of the TCR, CD69 and CCR7. Positively selected DP cells
also down regulate their expression of CD8, to an intermediate stage, and retain their CD4
expression. MHC II restricted cells will continue to have a sustained TCR signal resulting in
upregulation of the transcription factor Th-POK (T-Helper-Inducing POZ/Krueppel-Like
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Factor). Once the T-cell binds to an MHCII molecule and receives adequate notch signals, TCR
signaling will continue and GATA3 will be upregulated and Th-POK expression will continue
leading to development of a CD4 SP T cell. However, if the TCR signaling does not persist when
CD8 levels decline due to the expression of an MHCI restricted TCR, then Th-POK expression
will be inhibited by Runx3 causing IL7R to be expressed and the cell will commit to a CD8 fate.
Once an MHC molecule engages the TCR, it will cause the activity of Lck (a kinase) to
phosphorylate genes that will lead to either a CD4 or CD8 fate. However, if a DP T-cell cannot
make contact with an MHC molecule on the surface of the cTECs, either due to a nonfunctional
TCR or simply never coming into contact with an MHC, the cell will undergo apoptosis [17].
Thymocytes that have undergone successful positive selection will then express the
chemokine receptors CCR7 and CCR4, which will allow the cells to migrate to the medulla
following chemokine signals, as single positive (SP) T-cells [18]. In the medulla the T-cells will
undergo another level of selection, called negative selection. During negative selection, T-cells
will bind onto mTECs that uniquely express exogenous peptides in their MHC molecules that are
not native to the thymus. The mTECs express tissue-restricted antigens on their surface through a
process called promiscuous gene expression (PGE). PGE is carried out by the transcription
factors AIRE and Fezf2; AIRE allows the transcription of genes from areas that would found in
heterochromic regions of mTECs, whereas FezF2 binds directly to promoter elements of TRA
genes [10, 19, 20]. These gene products will be translated into proteins, processed into smaller
peptides and then packaged into the MHC molecules of the mTECs and expressed on the surface
of the cell. There a thymocyte will bind onto the complex via its TCR and depending on the
binding affinity the T-cell will either undergo apoptosis (binding too tightly) or go on to the
periphery to mount an immune response. This process ensures that the population of naïve T-
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cells that leave the thymus is self-tolerant and will not attack the body's own tissues. Figure 1
provides an overview of T-cell development and differentiation [6].
In order to maintain a proper immune system there are another class of T-cells that can
ablate an over reactive immune response. A special subset of T-cells, called Tregs can modulate
the autoreactive T-cells by making them anergic. Tregs are defined as CD4+ CD25+ Foxp3+, with
Foxp3 being the definitive marker of a regulatory T-cell. CD4+ Foxp3+ Tregs are generated in
the medulla alongside the conventional αβ T-cells. It has been shown that two subsets of
CD4+ thymocytes can give rise to CD4+ Foxp3+ cells; however, the mechanisms that govern the
lineage that lymphoid progenitors follow en route to becoming a CD4+ Foxp3+ cell has yet to be
elucidated [21]. In addition to these cells, there are more “unconventional T-cell” lineages that
arise from lymphoid progenitors, namely γδ T-cells and iNKT (induced natural killer T) cells.
The role of TECs in unconventional lineage generation is only partially understood. Currently it
is known that all unconventional T-cells are spawned in the cortex from either DN (γδ T-cells) or
DP thymocytes (iNKT-cells). Both populations have a more limited TCR repertoire and behave
more like innate cells which are immediately able to respond to antigens and secrete cytokines
when activated.

T-cells develop in a sequential order through the help of specialized epithelial cells in the
thymus. As described above, there are several levels of selection that occur in order to have selftolerant T-cells that can mount an appropriate immune response against a pathogen. Furthermore
T-cells are educated in order to prevent an autoimmune attack. These selection processes are
dependent on a properly organized thymic epithelial architecture. The crosstalk between
thymocytes and TECs allows not only the thymocytes to develop, but also the TECs. The need
for thymic crosstalk is apparent when looking at knockout mouse models that impede T-cell
5

development. For example, SCID mice (thymocytes arrested at DN2) [22], RAG-/- mice (arrested
at DN3) [23] and CαKO mice (arrested at DP stage) all have varying degrees of cortical
cellularity and organization, and lack fully formed medullas [24]. When double negative T-cells
are taken from a wild type mouse and are injected into the peritoneal cavity of any one of these
mouse models, both the cortex and the medulla goes on to develop similar to a wild type. These
rescue experiments show definitively that T-cell and TEC development are intimately locked
together.

Figure 1. Overview of T-cell development, adapted from Anderson and Jenkinson [6].
Fetal thymic development
The thymus develops from the endoderm of the third pharyngeal pouch at around
embryonic day 11 (E11). At E11, the area of the third pharyngeal pouch that is destined to be the
thymus and the parathyroid begin to extend away from the pharyngeal arch. From E11.5 to
6

E12.5, the thymic and parathyroid rudiments begin to separate into different domains: the
thymus driven by FoxN1 and the parathyroid by Gcm2 [25]. FoxN1 seems to be the key
transcription factor in leading to the formation of thymic epithelial cells, as shown by the lack of
a functional thymus in FoxN1-/- (nude) mice. Although FoxN1 is not required for organogenesis,
it is essential for committing to the TEC lineage [26-29]. Furthermore, in FoxN1 rescue
experiments, where FoxN1 is turned on later in development, the adult mice have fully
functioning thymuses [27, 30]. Interestingly, the thymic primordium is formed in FoxN1-/- mice,
but TECs are not formed, implying a critical role for FoxN1 in TEC development. Furthermore,
Rode et al. 2015 have shown that in the fetal thymus at least 94% of thymic epithelial cells
(defined by EpCAM) express FoxN1 throughout gestation [31]. At embryonic day 12, the
thymus has completely separated from the pharynx by the action of Hox family transcription
factors and by the neural crest cells that surround the outgrowth of the third pharyngeal pouch
[32, 33]. From embryonic day 12 forward, the thymus moves to the location it is found in adults
(above the heart in the chest cavity), and receives its first influx of lymphoid progenitors that are
fated to become T-cells [32]. This first influx of cells originates from the fetal liver, as the bone
marrow has yet to form [34]. There is another wave of lymphoid progenitors that colonize the
thymus at around E18 once the bone marrow has formed properly [31].

Cortical Thymic Epithelial Cells
The cortex of the thymus is the larger portion of the thymic epithelia, and is also the site
of positive selection. Cortical thymic epithelial cells (cTECs) express an array of markers such as
Ly51, the scavenger receptor DEC205, EpCAM, DLL4 (Delta-like ligand 4), cytokeratin 8, the
unique thymoproteosome subunit β5t, Prss16 (thymic-specific serine protease) and the
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chemokines CCL25 and CXCL12. cTECs attract thymic precursors by the secretion of the
chemokines CCL25 and CXCL12 which bind onto the chemokine receptors CCR9 or CXCR4,
respectively, found on ETPs. When they interact with cTECs, they are committed to the T-cell
fate. This fate determining decision is aided by the presence of DLL4, a cell surface Notch
ligand. Furthermore, DP thymocytes interact with cTECs during positive selection, which allow
them to continue development into single positive T-cells. Positive selection occurs by the
interaction between DP T-cells and either an MHC I/II molecule with a self-peptide complex
found on these cTECs.
To become a CD4 T-cell a DP thymocyte must interact successfully with an MHC II
molecule and self-peptide, whereas CD8 cells interact with MHC I molecules and self-peptides.
The process by which these self-peptides are generated are vastly different in terms of the
proteins involved in their genesis. For MHC I loading the essential protein is encoded by the
Psmb11 gene which encodes the unique cTEC specific proteasome β5t. This proteasome breaks
down exogenous proteins and degrades them to be packaged into the MHC I molecule. In
Psmb11-/- mice, there was a marked reduction in the presence of CD8+ thymocytes. However,
while there was a small population of CD8+ cells, they showed impaired immune function
giving credence to the essential role of β5t in CD8 cell production and function. On the other
hand, MHC II loading is driven by the proteases cathepsin-L and thymic specific serine protease
(tssp), which break down cytosolic proteins. These degraded products are then loaded into the
MHC II molecule in the endoplasmic reticulum and then transported to the surface of the cell to
be presented [13].
cTECs also contain a unique subset of cells called thymic nurse cells (TNCs). These cells
are singular cTECs that can encapsulate multiple thymocytes and can be identified by the
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antibody PH91 [35]. While the thymocytes are in this TNC complex, they can undergo
secondary TCRα gene rearrangements giving thymocytes that were previously deemed for
apoptosis, another chance to become a functional T-cells [35-37] .

Medullary Thymic Epithelial Cells
The medulla of the thymus is critical in developing self-tolerance; here, developing
thymocytes are introduced to self-peptides from a wide array of organs in order to prevent auto
immune attack. However, this is not the medullas only role. Medullary thymic epithelial cells
(mTECs) are also involved in the development of regulatory T-cells and other unconventional Tcell lineages. Through negative selection, mTECs express a plethora of tissue-restricted antigens
(TRAs). The mTEC population is characterized as the Ulex Europaeus Agglutinin Type 1 (UEA1) binding subpopulation in the EpCAM expressing TEC population. Apart from UEA-1 binding
mTECs are defined by cytokeratin 5 (K5), cytokeratin 14, Claudin3/4, CD80, AIRE
(autoimmune regulator), Fezf2 and Cathepsin-S. mTECs are heterogeneous in nature with
postnatal mTECs having two major subpopulations defined by the expression level of MHC II
and CD80: mTEClo (MHCIIlo CD80lo) and mTEChi (MHCIIhiCD80hi). Initially, it was thought
that the mTEClo population was the immature portion of the medulla, but it has been shown that
this is also a heterogeneous population [38]. The mTEClo population has both immature mTECs
and a terminally differentiated population of mTECs, further defined by involucrin expression
[38].
Thymocytes that have undergone proper positive selection enter the medulla by following
the chemokine signals produced by mTECs, mainly CCL21. Once the single positive T-cells
enter the medulla they will undergo negative selection, which is mediated by the transcription
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factors Fezf2 and AIRE in a process known as promiscuous gene expression (PGE) [39-41]. As a
whole, PGE promotes the expression of genes from exogenous sources that would not otherwise
be expressed in the thymus. This allows the presentation of proteins to educate the ISPs on self
vs non-self. Importantly, Fezf2 and AIRE seem to produce some gene products that overlap but
have many genes that are mutually exclusive to either AIRE or Fezf2 [39].
The development of AIRE+ and Fezf2+ mTECs is closely tied to the development of Tcells and is an excellent example of crosstalk. For T-cells to properly develop they need survival
signals that will be provided by the mTEC. It can go on into the periphery and mount an immune
response. Counterintuitively, for an mTEC to become an AIRE or Fezf2 expressing cell it also
requires signaling from a T-cell. It has been shown that AIRE and Fezf2 are maintained by the
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway[5, 10,
39, 42, 43]. A key activator of that pathway is RANK-L (Receptor activator of NF-κB) which is
expressed on the surface of T-cells. RANK-L binds to RANK (found on the surface of mTECs)
and leads to the development of AIRE+ mTECs. There are disputing arguments as to how Fezf2
arises in mTECs. Takaba et al. has stated that LTBR signaling leads to Fezf2+ mTECs [10],
whereas Cosway et al. has stated that Rank signaling leads to Fezf2+ mTECs [43]. Figure 2
provides an overview of the differential protein expression patterns found on cortical and
medullary thymic epithelial cells.
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Figure 2. Differential protein expression patterns found on cortical and medullary thymic
epithelial cells.

The role of Thymic Fibroblasts in TEC development
The thymic stroma contains a multitude of cells apart from the epithelial compartment.
The mesenchymal component arises from neural crest cells (NCCs); at embryonic day 12 (E12)
the newly forming thymic rudiment is surrounded by NC derived mesenchymal cells [44]. These
mesenchymal cells then form a fibroblast network at E13 and give rise to the thymic capsule [3,
45, 46]. These mesenchymal cells have been shown to be involved in both T-cell and TEC
development. It has been shown that an E12 fetal thymus, without a proper fibroblast network,
was not able to produce T-cells beyond the double negative stage, which will lead to impaired
TEC development due to the lack of crosstalk between the developing T-cells and the thymic
11

epithelial cells [3, 47]. Furthermore, these fibroblasts can provide soluble factors, such as
fibroblast growth factor (FGF), that can induce the proliferation of TECs that express FGF
receptor [48-50].
It has also been demonstrated that fibroblasts are crucial in TEC development and
maintenance. FGF7 administration following irradiation has been shown to promote the
regeneration of the thymus, through the activation of the NF-kB and p53 pathway [51]. More
recently, a subpopulation of fibroblast cells expressing the S100 superfamily protein FSP1
(fibroblast specific protein-1) has been shown to maintain and induce proliferation in mTECs
[52]. Interestingly, FSP-1 deletion has been shown to disrupt the architecture of the adult
thymus, lower the expression of MHCII on TECs, and dramatically decrease the number of
mTECs [52]. Lastly, FSP-1 is also an epithelial-mesenchymal transition marker, so it can be
posited that these cells may have been derived from thymic epithelial cells and are maintaining
the developing TECs. Determining the source of these FSP-1+ cells and their action in TEC
maintenance may unlock new methods in maintaining the thymus and fighting the involution of
the thymus.

Thymic Involution and Loss of T cell Function
As opposed to its key role in maintaining the one half of the adaptive arm of the immune
system, the thymus is one of the first organs to undergo involution. 3% of thymic tissue is
estimated to be lost per year at puberty and then at 1% per year in middle life [53]. Thymic
involution is a decrease in the epithelial compartment of the thymus, which causes an increase of
perivascular space. Concurrent with a gradual decrease in thymic size there is an increase in
connective tissue and adipose tissue [54, 55]. The thymus also undergoes increased atrophy due to
infection, glucocorticoid treatment, chemotherapy and radiotherapy. These causing factors primarily
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affect the T-cell population; for example, glucocorticoid treatment induces apoptosis of the DP
thymocytes, or chemotherapy and radiotherapy cause major loss of hematopoietic cells, including Tcells at various developmental stages. Acute loss of developing T-cells leads to less thymic crosstalk, which leads premature thymic involution [56]. This progressive loss of the thymic stromal

components ultimately leads to the loss of naïve T-cells and a diminished immune response.
However, the total number of T-cells in the periphery does not change significantly. When taking
the fact that there is a loss of naïve T-cells, it shows why the elderly and those undergoing
chemotherapy are at risk for illnesses caused by pathogens that are new to the population.
Thymic involution appears to be driven by epithelial to mesenchyme transition, which
results in fibroblasts that eventually become adipocytes. However, there seems to be ways to
counteract this involution. Olsen et al. 2001, have shown that thymic epithelium has androgen
receptors present on the surface of the cells and that treatment of these cells with the testosterone
analogue dihydrotestosterone (DHT) leads to a decreased cellularity in both in vivo and in vitro
experiments [57]. Seeing these trends when 2-year-old male mice were surgically castrated, the
thymic microenvironment was very similar to that of 2-month-old male mice. These results
suggest that there may be a progenitor or stem-like population in the thymus that can reconstitute
the epithelial compartment. Hence, with the ability to understand the mechanisms involved in the
patterning of the thymus as well as the capability to isolate TEC progenitors, one could attempt
to reconstitute the thymic microenvironment in vitro or in vivo using postnatal TEC progenitors.
This could be used as a preventative measure to increase the repertoire of T-cells in aging
patients as well as reconstitute a functional immune system faster in patients undergoing
chemotherapy.
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Thymic Epithelial Cell Progenitors
It was believed that both the ectoderm and the endoderm of the third pharyngeal pouch
gave rise to the earliest thymic rudiment. The dual origin theory as it was known, stated that the
cortex is derived from the ectoderm and the medulla arises from the endoderm [58-61].
However, Gordon et al., 2002 experimentally proved that the thymus actually arises from the
third pharyngeal pouch in a series of elegant experiments in which they dyed both the endoderm
and the ectoderm and checked for the presence of the dye in the thymic rudiment [2, 61, 62].
This new theory definitively showed that the thymus has a single origin, specifically arising from
the endoderm of the third pharyngeal pouch. Furthermore, it led to speculation about a bipotent
progenitor population that can give rise to both the cTEC and mTEC portion of the thymic
stroma.
The embryonic thymus is thought to contain thymic epithelial progenitor cells (TEPC)
that can give rise to both mTEC and cTEC lineage progeny. Rossi et al. has shown that
EpCAM+ CD45- eYFP+ cells from an E12 fetal thymus can give rise both mTECs and cTECs
[63]. For the first time this paper showed that, at least in the fetal thymus, there is a progenitor
population that can give rise to cells that constitute both compartments of the thymus stroma.
However, there is clearly much work to be done in order to elucidate this TEPC population and
to determine whether it persists in the adult thymus.
While it seems apparent that there is a bipotent TEC population in the fetal thymus, the
presence and phenotype of an adult bipotent TEPC is a subject of much debate [64-66]. Ucar et
al. 2014, has shown that adult TECs contain a population of low cycling cells, with a selfrenewal capacity, that can form miniature thymuses in vitro called thymospheres, which contain
both mTECs and cTECs. They also demonstrated that this population of cells arise from FoxN1-
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cells [64]. Ulyanchenko et al. 2016, has shown that Ly-51+ Plet-1+ MHCII hi cells define a
potential TEPC population in adult thymus [65].
Several studies have actually shown that some cTEC markers like Dec205 and the unique
thymoproteosome b5t define the progenitor cell population of thymic epithelia [9, 67]. Up until
very recently it was thought that DEC205 was a marker for cTECs. However, in 2013 it was
shown that DEC205+ cells can give rise to both cTEC and mTEC [9]. Two different studies
reported that a b5t-expressing progenitor population gives rise to the majority of mTECs [67,
68]. These studies for the first time showed that DEC205 actually defines both cTECs and can be
used as a marker for TEPCs. Osada et al. 2013, previously utilized a label retention model to
identify a stem cell like population within the postnatal thymus which has the capacity to
differentiate into both TEC subsets in vivo as well as multiple mesenchymal lineages including
adipocyte, chondrocyte and osteoblasts in vitro [69]. They characterized this population by the
expression of Sca1, CD49f, CD29, PDGFRa and CD90 [69]. Later, Wong et al. 2014
recapitulated these data and showed that a subset of EpCAM+ cells expressing a MHCIIlo Sca1+
CD49f+ phenotype, from an adult thymus was capable of differentiating into both cTECs and
mTECs [66]. Though there have been extensive studies on the presence of thymic epithelial
progenitor cells (TEPC) in adult thymus, no consensus has been formed on the definitive
characteristics of this population. Characterizing the TEPC population is important as they can
be used in therapeutics for improvement of thymic function.

Bone Marrow Derived Epithelial Cells
It is known that the bone marrow (BM) contains hematopoietic stem cells, which give
rise to lymphoid and myeloid lineage cells. Very recently, it has been shown that BM derived
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cells can actually give rise to many different cells that do not “traditionally” originate in the BM,
namely hepatocytes, skeletal muscle cells, airway epithelial cells and neurons. Ferrari et al. 1998,
showed for the first time that bone marrow derived cells can migrate to the site of regenerating
muscle fibers and participate in the regeneration of the damaged fibers by becoming skeletal
muscles [70]. Later in 2000, Mezey et al. showed that adult bone marrow cells can migrate to the
brain and differentiate into cells that express neuronal-specific antigens [71]. Theise et al. 2000,
showed that both rodent and human bone morrow derived cells can differentiate into hepatocytes
[72, 73]. Wong et al. 2007, has shown that short-term cultured bone marrow cells migrated to the
murine lung, in a naphthalene injury model, and differentiated into airway epithelial cells [74].
Wong et al. 2009, expanded on that work and showed a population of cells in the bone marrow
express a marker of lung epithelia, Clara cell secretory protein (CCSP) and the hematopoietic
cell marker CD45. In addition, they demonstrated that the frequency of this population increases
in response to lung injury [69].
Krause et al. 2001, showed that hematopoietic lineage depleted cells isolated from the
bone marrow and transplanted into irradiated mice homed to bone marrow after only two days
[75]. These cells are then recovered from the recipient mouse and single cells were then injected
into new hosts. After 11 months, these cells were present in different organs including the liver,
stomach, lung and skin. Strikingly, staining studies have showed that these cells had truly
differentiated into epithelial cells in multiple organs [75]. Recently some studies have shown that
this phenomenon of BM derived cells contributing to epithelial organs has been disputed. These
studies have shown that following a bone marrow transfer (BMT), BM derived cells can fuse to
epithelial cells, forming BM derived synkaryons [76]. BM derived synkaryons have been
observed in myocardium [77, 78] and hepatocytes [79]. However, synkaryon formation after
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BMT has been shown to be a rare phenomenon [78], so it is quite possible that a population of
cells can truly transdifferentiate from hematopoietic to epithelial in nature. This ability of bone
marrow derived cells can be used for the targeted cell replacement therapy for different organs.
Taken together, these studies have shown that there is much to be learned about BM derived
cells, and that they may be more plastic than previously understood.
Our lab is interested in identifying TEC progenitors /stem cells capable of reconstituting
a complete thymus. We previously used the stem cell property of label retention, by exploiting
their slow proliferation, to identify a subset of TECs which express the cTEC marker
DEC205/BP1 together with Sca1 and the alpha 6 and Beta 1 integrins [69]. This subset was
partially able to reconstitute a complete thymus. However, we believe this may be only a partial
phenotype, due to limitations of our isolation methods. TECs represent a small subset of the total
thymus which contains 109 thymocytes and only 5 x106 TECs. To study and characterize TECs,
the thymus is dissociated with enzymes and then TECs are enriched, when hematopoietic cells
are depleted with CD45 magnetic beads. Using this approach, the population of TECs is always
reduced in cTECs (by DEC205 expression), which are thought to contain the TEC progenitor
subset [9,59-62]. CD45 is assumed to be restricted to hematopoietic cells, yet despite the use of
CD45 beads to remove CD45 expressing thymocytes, we and others routinely find a subset of
CD45+ EpCAM+ cells in our analysis which was previously ignored and assumed to be TNC
complexes of cTECS with enclosed thymocytes [80]. We have sorted BM and thymus derived
CD45+ EpCAM+ cell populations and our results suggest they are a true population that can give
rise to both thymic epithelial cells and thymic fibroblasts. It has been shown that CD45+ cells
can give rise to epithelium in mice [81]. We believe that these double positive cells give rise to
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both TECs and fibroblasts. The goal of this work is to better characterize this EpCAM+ CD45+
population and determine its origins as well as its functional role in the thymus.

Materials and Methods
Ethics statement
All mice used in this study were bred and maintained at the City College of New York animal
facility and all experiments were performed with approval from the City College of New York
Institutional Animal Care and Use Committee. The animal care facility at the City College of
New York is certified at both the State and Federal levels. The CCNY animal assurance number
is A3733-01.
Mice
C57BL6 mice purchased from Jackson Laboratory were used for this study. The ages of the mice
ranged from 3-4 months. Actin H2BGFP mice were purchased from the Jackson Laboratory (Bar
Harbor, ME). Rosa26 mRFP mice were purchased from the Jackson Laboratory (Bar Harbor,
ME).
Antibodies
The following primary antibodies were used for experiments: CD45-PE Cy7, CD45-APC Cy7,
CD45 APC (clone 30-F11, BD Bioscience), cytokeratin 5 (MK-5, Covance), cytokeratin 14
(MK-14, Covance), Troma I (Developmental Studies Hybridoma Bank, IA), ΔNP63 (clone N16, Santa Cruz), EpCAM-PE (clone G8.8, eBioscience), Sca1-PE Cy7, Sca1-APC Cy7(clone D7,
eBioscience), CD49F-Biotin (eBioGoH3, eBioscience), CD29-PE Cy7(clone Ha2/5,
eBioscience) , Laminin (Millipore). CD44-APC (clone IM7, BD Bioscience), CD90.2(clone 30H12, BD Bioscience), CD34-PE (clone RAM#4, eBioscience), SSEA1(clone MC480, Stem Cell
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Technologies), Rabbit anti-GFP (Life), CD80 (eBioscience), and CD205 (LY75/DEC-205) clone
HD30 (Millipore), Rat IgG2a isotype-PE, Rat IgG2a isotype-FITC, Rat IgG2a isotype-PE-Cy7,
Rat IgG2a isotype-PerCP Cy5.5, Rat IgG2a isotype-APC Cy7, Rat IgG2a isotype-APC and Rat
IgG2a isotype-Biotin (BD Bioscience). The following secondary reagents were used for
experiments: donkey anti rabbit IgG-TRITC, donkey anti rabbit IgG-Cy5, donkey anti rabbit
IgG-FITC, donkey anti rat IgG-TRITC, donkey anti goat IgG-FITC, goat anti rat IgM-TRITC
(Jackson ImmunoResearch), anti-rat IgG2a-FITC, anti-rat IgM-FITC, streptavidin-APC,
stretavidin-APC Cy7, streptavidin-PerCP Cy5.5 (BD Bioscience) and stretavidin-TRITC
(Southern Biotechnology Associate).
Preparation of Thymic epithelial cells (TECs)
Thymi were extracted from sacrificed mice and were cleansed of fat and blood in ice cold
phosphate buffered saline (PBS). The clean thymic lobes were then cut into four smaller pieces
and transferred into a tube containing PBS, which were then pipetted up and down several times
using a glass Pasteur pipette with varying bore widths, starting with a wide bore and decreasing
the width down to the smallest possible size; this was done to remove T-cells. The remaining
tissue was placed into a 3-mL dissociation solution (Hanks Balanced Salt Solution (HBSS) with
5% Fetal Bovine Serum (FBS) and 500 uL of DNase I) and incubated in a 37°C water bath for
15 minutes. The tissue solution was pipetted up and down at 7.5 minutes with a Pasture pipette to
aid in tissue dissociation. The solution was removed, centrifuged at 3000 rpm for 5 minutes at
4°C and resuspended in HBSS with 5% FBS. The undigested tissue was placed into new
dissociation solution and the above steps were repeated once more, for a total of three
dissociations. The digested tissue fractions were then filtered through a 100 µm strainer and
pooled into one tube.
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The pooled sample was counted at a ratio of 1:100 on a hemocytomer. The cells were
incubated with antibody, depending on method of depletion, at a ratio of 0.5 µL/106 cells on ice
for 10 minutes. During the antibody incubation, Sheep anti-Rat IgG Dynabeads or Biotin binder
beads (depending on depletion) were washed with HBSS containing 1% EDTA. After ten
minutes the cells were placed into the bead solution and were depleted for cells staining for the
corresponding antibodies. This ensured a higher amount of both TECs and CD45+ EpCAM+
cells.
Isolation of Bone Marrow cells
Bone marrow cells were isolated by removing both the femur and tibia of the mouse and
removing all the flesh and muscle from the bone. Then the patella was removed using a scissor
and the bone marrow was exposed. The bone was placed into a 500 uL Eppendorf tube with a
hole made in the bottom by a 28-gauge needle. The bone and the tube were placed into a 1.5 mL
Eppendorf tube with the cap open, which was then centrifuge at 12,000 x g for 15 seconds. Then
the supernatant was suspended in 1X PBS. For a detailed protocol refer to:
http://www.jove.com/video/53936/murine-hind-limb-long-bone-dissection-and-bone-marrowisolation.
Involution of Adult Thymus
To induce premature involution of the adult thymus, C57BL6 mice were injected with 5
CCs of dexamethasone (8 mg/ml).

Immunohistochemistry of Adult Thymic sections
Briefly, dexamethasone injected mice were sacrificed, and their thymuses were removed.
Thymuses were then embedded in OCT compound from Tissue-Tek. Sections were cut using a
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cryostat and mounted on to slides. The slides were then fixed in 4% paraformaldehyde (10
minutes), washed with PBS three times, placed into acetone (10 minutes), washed more times
and blocked with Complete normal donkey serum (1% Normal donkey serum in Bovine serum
albumin). Then, antibodies were added, and the slide was placed into a humid chamber
overnight. Secondary antibodies were applied, if needed, and slides were sealed following
application of DAPI.
Reaggregate Thymic Organ Cultures (RTOC)
Briefly, bone marrow/thymic cells were isolated from Actin H2BGFP mice and were
placed in single cell suspensions as described above. From these cells the EpCAM+ CD45+
CD11B- CD11C- CD19- cells were isolated and mixed with fetal cells from a C57BL6 thymus
to form a reaggregate. These reaggregates were then placed on a transwell filter in RP10 media
and incubated at 34 (Degrees) C for 3 days. The aggregates were imaged before they were placed
under the kidney capsule for the presence of H2BGFP. After three weeks, the kidneys were
isolated and sectioned.
Organ transfer experiments
Fetal thymuses were isolated from E14.5 C57BL6 or Actin H2BGFP mice, as stated, and
placed into the kidney capsule of either an Actin H2BGFP mouse or a Rosa26 mRFP mice,
respectively. Following a time course of 3, 6, 9 or 12 weeks the kidneys were isolated, and half
of the exogenous thymuses were used for flow cytometric purposes, while the others were used
for immunohistochemistry.

RNA extraction from sorted cells
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Cells are stained and sorted into Trizol LS to greater than 90% purity, pipetted up and
down and incubated at room temperature for 5 minutes. Then, 200 µL of chloroform is added for
every 750 µL of trizol. The mixture is then vortexed for 15-30 seconds and incubated at room
temperature for 10 minutes. The sample is centrifuged at 12,400 RPM for 15 minutes at 4oC. An
equal amount of 70% ethanol is added and mixed and the solution is then transferred into an
RNEasy spin column and centrifuged for 1 minute at 11,000 RM. 700 µL of RW1 is added and
the solution is centrifuged for 1 minute at 11,000 RPM, 500 µL of Buffer RPE is added and then
centrifuged at 11,000 RPM for 1 minute, then 500 µL of 80% ethanol is added and centrifuged
for 2 minutes at 10,000 RPM. The collection tube is changed, and the tube is centrifuged with the
cap open at full speed. 16 µL of RNase-free water is added and the RNA is eluted by spinning at
full speed for 1 minute.
CDNA synthesis
cDNA is then synthesized from the extracted RNA. The RNA is denatured by adding 1
µL of both random hexamers and dNTPs for every 12 µL of RNA. The sample is then placed
into a thermocycler using the settings found in Table 1. Then, for every 14 µL of denatured
RNA: 4 µL of 5X buffer, 1 µL of DTT, 0.5 µL of SSIII, and 0.5 µL of RNase inhibitor is added.
This is placed into a thermocycler using the settings found in Table 1.
Table 1. Settings for thermocycler.
Denature RNA
Temperature Time
65 C
5 min
cDNA synthesis
Temperature Time
25 C
10 min
50C
50 min
85 C
5 min
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Results
Presence of a CD45+ EpCAM+ population in the thymus
Using standard enzymatic digestion of thymic tissue in conjunction with CD45 magnetic
bead depletion of hematopoietic cells, we observed a persistent but rare population of cells that
co-expressed both CD45+ and EpCAM+ (DP). This population has been noted in several
publications; however, they were identified as thymic nurse cells, which are complexes of cTECs
with internalized CD45+ thymocytes [80, 81]. We sought to enhance the isolation of this
population by depleting T-cells in our enzymatically dissociated thymic tissue using antibodies
against CD3, CD4, CD8, CD11b, CD11c, and CD19 together with magnetic beads rather than an
anti-CD45 antibody. Using this alternative depletion method, the new CD45+ EpCAM+
population was found to be enriched (37.6%, using the new depletion approach, versus 3.61%,
using CD45 depletion, of total EpCAM+ cells) (Figure 3), suggesting that we and others in the
field may be losing a large percentage of EpCAM+ cells by ignoring this population, including
potential progenitors.
Next, we wanted to analyze a fetal thymus for the presence of these double positive cells
to see if they are present during the development of the fetal thymus as well as in the postnatal
thymus. If the CD45+ EpCAM+ population does truly contain a thymic epithelial progenitor cell
(TEPC) population, then these cells should be present in the fetal thymus as well as the postnatal
thymus. Thymi were isolated from fetal C57BL6 mice at embryonic days 13.5, 15.5 and 18.5.
Thymi younger than embryonic day 16.5 were not depleted for CD4, CD8, CD11b, CD11c or
CD19, due to the low number of cells found at these days. At E13.5 the DP population is
0.020%; at E15.5, this rises to 3.58% and then decreases to 0.12% of the CD11b- CD11c- CD19cells at E18.5 (Figure 4).
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Next, we wanted to know if this population was truly co-expressing CD45 and EpCAM
or if these cells were formed because of epitope sharing or ruptured TNC complexes as
suggested by others [80]. We show them to be single cells, when careful doublet discrimination
is performed during flow cytometry. CD45+ EpCAM+ cells were isolated from an adult thymus
based on their phenotype using a FACS sorter and they were confirmed to be true double
positive cells by immunohistochemistry (Figure 5). Control population of cells that were either
CD45+ EpCAM- or CD45- EpCAM+ were also sorted and viewed under a fluorescence
microscope to ensure that our antibodies were working properly and that they were single cells
co-expressing both CD45 and EpCAM (Figure 5). Since thymic derived DP cells expressed
CD45, we hypothesized that they may be bone marrow derived and migrating into the thymus
similar to other hematopoietic cells. We analyzed the bone marrow of the mice to see if there
was a CD45+ EpCAM+ population present there (Figure 6). Furthermore, recent literature has
shown that a bone marrow derived CD45+ EpCAM+ population can give rise to lung, uterine
and cardiac epithelial cells. EpCAM- CD45+ cells were also sorted from the bone marrow to
confirm the staining of CD45 (Figure 6); cells that only express EpCAM however were not
found in the bone marrow.
To provide further evidence for the presence of this unique population, we sought to see if this
population can be found in an intact adult mouse thymus. However, in an adult mouse thymus,
CD45+ cells far outnumber TECs. To better visualize these cells, we injected C57BL6 mice with
dexamethasone to specifically reduce the number of double positive thymocytes, the most
abundant CD45+ cells in the thymus. Then, after 3 days, the mice were sacrificed, and their
thymuses were harvested, sectioned, mounted on slides and stained for both CD45
(hematopoietic) and Pan-Keratin (epithelial). There appear to be some cells that share
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hematopoietic (CD45) and epithelial (Pan Cytokeratin) characteristics in the intact thymus.
However, these cells were quite rare and difficult to find (Figure 7).

Figure 3. Alternative hematopoietic cell depletion enriches CD45+ EpCAM+ population. ACD45 depletion shows 3.77% of all EpCAM+ cells co-express CD45 and EpCAM. B- Using an
alternative depletion method using CD4, CD8, CDllb, CDllc CD19, CD3, 37.6% of all EpCAM+
cells co-express CD45 and EpCAM.

Figure 4. CD45+ EpCAM+ cells are found as early as embryonic day 13.5 and persist throughout
gestation. It is important to note that this is before both DP thymocytes and TNCs appear in the
thymus.
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Figure 5. Sorted thymic CD45+ EpCAM+ cells show surface level expression of CD45 and EpCAM. CD45+ EpCAM+ cells were
sorted and analyzed for CD45 and EpCAM expression along with CD45 only and EpCAM only cells from the thymus, to confirm true
staining. Cells of interest are enlarged in the insets and represent the cells shown in the white boxes.
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Figure 6. Bone marrow derived CD45+ EpCAM+ cells show surface level expression of CD45 and EpCAM. CD45+ EpCAM+ cells
were sorted and analyzed for CD45 and EpCAM expression along with CD45 only cells from the bone marrow, to confirm true
staining. Cells of interest are enlarged in the insets and represent the cells shown in the white boxes.
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Figure 7. Presence of CD45+ EpCAM+ cells in an intact adult thymus. Adult C57BL6 mice were injected with dexamethasone in
order to better visualize an individual CD45+ PanK+ cell. On the left is an orthogonal view of a thymus section, on the right is a
Maximum intensity 2.5D projection with an inset of an individual cell expressing both CD45 and PanK.
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Analysis of RNA isolated from bone marrow and thymus
To further validate these cells, we conducted quantitative rt-PCR on sorted CD45+
EpCAM+ cells from the bone marrow and thymus (sorted to 95% purity) to determine the
relative levels of expression of either CD45 or EpCAM compared to 18s rRNA, to thoroughly
rule out epitope sharing as the cause of this unique population (Figure 8). All RNA isolated for
these experiments were diluted to 5 ng/µL, to exclude differences in RNA amounts; further all
results are normalized to 18s rRNA. In terms of CD45 expression, BM derived CD45+ cells had
five times higher levels of CD45 RNA relative to the CD45+ EpCAM+ population (Figure 8A).
When EpCAM expression was compared, CD45+ cells showed no detectable EpCAM
expression while the double positive population showed close to 110 times higher levels of RNA
relative to the CD45 only population derived from BM (Figure 8B). This indicates that the
double positive population expresses both CD45 and EpCAM, albeit CD45 expression is lower
in the double positive population. In the thymus, DP cells had half the expression of CD45 RNA
compared to CD45 only cells, whereas the EpCAM only population had no detectable expression
of CD45 RNA (Figure 8C). In terms of EpCAM expression, DP cells had half the expression of
EpCAM+ cells and the CD45 only cells had no detectable level of EpCAM (Figure 8D). Further
analysis of single sorted cells will be performed to confirm these results and exclude sort purity
issues.
Collectively, these data show that there is a population in both the thymus and the bone
marrow that express CD45 and EpCAM. These cells have been shown to be present in both the
adult and the fetal thymus as well as in the bone marrow. We have shown that these cells truly
express both CD45 and EpCAM at both the protein and RNA levels, confirming that these cells
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are truly double positive cells. Next, we sought to show that these cells can contribute to the
maintenance of thymic stroma in an in vivo system.
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Figure 8. Bone marrow and thymus derived CD45+ EpCAM+ cells show presence of CD45 and
EpCAM mRNA. All RNA was normalized to 5 ng/µl. 18s rRNA was used as a housekeeping
gene in order to compare relative amounts of RNA expression. A and B show relative CD45 and
EpCAM expression, respectively, in BM sorted cells. C and D show relative CD45 and EpCAM
expression, respectively, in sorted thymic cells.
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A peripheral population can migrate into the developing thymus and give rise to thymic stroma
In order to see if CD45+ EpCAM+ cells can migrate into a developing thymus and
contribute to thymic stroma, fetal thymuses were isolated from an E14.5 C57BL6 mice and
placed under the kidney capsule of an Actin-H2BGFP mouse, thus allowing detection of
peripheral cells migrating into the thymus through the expression of H2BGFP in the nucleus.
These mice were then sacrificed at 3, 6, 9 or 12 weeks after grafting and the thymuses were
isolated and analyzed either through histology or flow cytometry. This would allow us to
visualize the contributions of peripheral cells to thymic stroma. As the fetal thymus is developing
it is hypothesized that a peripheral population will enter and contribute to the growing thymus,
with the assumption that the population entering is the CD45+ EpCAM+ from the bone marrow.
Although there is a large TEC population (EpCAM+) at week 3, however these cells are
not GFP+ (0.73%) indicating that these TECs are from the original fetal thymus. In contrast,
39.47% of the CD45+ EpCAM+ express H2B-GFP. At week 6, the CD45+ EpCAM+ GFP+
population stays relatively similar to the week 3 result (43.03%). Interestingly, the CD45EpCAM+ GFP+ population increases to 3.90% showing that there is a peripheral population that
is migrating in and contributing to fetal thymic epithelial development. Week 9 shows that the
CD45+ EpCAM+ GFP+ population has further increased to 53.17%, whereas the CD45EpCAM+ GFP+ population has decreased to 3.07%. At week 12, the CD45-EpCAM+ GFP+
population represents 9.62% of total TECs, and the CD45+ EpCAM+ GFP+ population
represents 45.83% of total CD45+ EpCAM+ cells (figure 9 and 13). In terms of absolute
numbers, the EpCAM+ GFP+ population increased from 223 to 1189 to 1077 to 2155 cells in
weeks 3, 6, 9 and 12, respectively (Figure 11). Overall, CD45+EpCAM+GFP+ cells represent
approximately 40-50% of all CD45+ EpCAM+ cells, whereas EpCAM+ GFP+ cells make up ton
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10% of all TECs (Figure 12). All results were replicated at least 4 times. Taken together, these
results show that a peripheral population of cells can contribute to thymic epithelium. However,
this contribution is not a major portion of total TECs. The major contribution of peripheral cells
seems to be to the CD45+ EpCAM+ population.
When thymuses were analyzed histologically in parallel experiments at the previously
indicated time points, a combination of PanK+ FoxN1+ GFP+ and PanK+ FoxN1- GFP+
populations were found as indicated by white and red arrows in figure 14, respectively. In order
to ensure that all Actin-H2BGFP expressing cells are detected, we stained an Actin H2BGFP
thymus for PanK and FoxN1 (Figure 13). Since FoxN1 and PanK are definitive markers of
thymic epithelium, this indicates that there may be a transition stage in which PanK+ FoxN1become PanK+ FoxN1+ or vice versa.
Recently, evidence has been mounting that the scavenger receptor CD205 (DEC205),
marks not only the cortical portion of the thymus, but also a progenitor population for thymic
epithelial cells [9]. When thymuses that had been grafted onto Actin H2BGFP kidneys were
analyzed for UEA1 (an mTEC marker) and DEC205 (cTEC marker), the thymus looked quite
unorganized at weeks 3 and 6, as expected due to the use of a fetal thymus for engraftment
(Supplemental Figure 1). However, at weeks 9 and 12, the thymus looks like a properly
organized adult thymus with distinct medullary and cortical areas, defined by UEA-1 and
DEC205, respectively. Upon analyzing the data there seems to be some DEC205 cells in UEA1
regions that express GFP. This population is a bit more abundant at week 12 but it is still quite
rare. Strikingly, there is a cell that expresses both UEA-1 and DEC205 at week 9 (see inset);
thus, it is plausible to think that this cell is potentially giving rise to an mTEC cell (Figure 15).
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The amount of cells that stain for PanK and FoxN1 do not encompass the vast majority of
GFP+ cells detected. Out initial hypothesis was that some of the GFP-expressing cells detected
in the growing fetal thymus were T cell progenitors being recruited into the thymus from the
BM. However, staining for T cell markers (data not shown) showed that many GFP+ cells were
not T-cells, either. Recently, Sun et al. has shown that FSP1 expressing cells help to maintain
medullary thymic epithelial cells [52]. When we analyzed this tissue for FSP1 expression we saw
that FSP1+ GFP+ cells were found at all timepoints analyzed (Figure 16). The percentage of
FSP1 expressing GFP cells stayed relatively the same at all timepoints analyzed ranging from
50-70% of all GFP+ cells (Figure 15). In order to truly compare how many cells coexpress FSP1
and GFP across timepoints, we normalized the amount of GFP+ cells to mm2 of FSP1 area
(Figure 18). We saw that the relative amount of GFP+ cells/mm2 FSP1 area increased from week
3 through 9, then decreased at week 12; peaking at 9465 GFP+ cells/mm2 FSP1 at week 9.
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Figure 9. A peripheral population can give rise to both CD45+ EpCAM+ cells as well as
EpCAM+ cells. C57BL6 fetal thymuses were injected into the kidney capsule of Actin H2BGFP
mice. Cells of a non-thymic origin should express the H2BGFP fusion protein. The left plots
show all CDllb- CDllc- CD19- cells gated for CD45 and EpCAM. The middle and right graphs
show EpCAM+ and CD45+ EpCAM+ cells’ H2BGFP expression levels, respectively.
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Figure 13. The expression of PanK FoxN1 and GFP in a normal Actin H2BGFP thymus section.
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Figure 14. Histological analysis of thymuses grafted onto Actin H2BGFP kidney capsules. White arrows indicate cells that express
PanK, GFP and FoxN1. Red arrows indicate cells that express PanK and GFP but not FoxN1.
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Figure 15. A peripheral population might contain a thymic epithelial progenitor population. In the bottom two rows, an individual cell
is shown to express DEC205, a known TEPC marker along with H2BGFP. White arrows indicate other cells that express DEC205 and
H2BGFP.
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Figure 16. A peripheral population may be the source of thymic fibroblasts. Thymuses were isolated from organ transfer experiments
and analyzed for FSP1 at each respective timepoint. White boxes indicate areas that are enlarged in the insets on the bottom left.
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Reaggregate thymic organ culture (RTOC) of BM or Thymus derived CD45+ EpCAM+ cells
Collectively, the presence of GFP+ cells migrating into fetal thymic lobes transplanted under the
kidney capsule, shows that a peripheral population can give rise to thymic stromal compartments
in developing fetal thymuses. However, the source of this population has yet to be identified. In
order to do this, we isolated CD45+ EpCAM+ cells from either the bone marrow or the thymus
of Actin H2BGFP mice and RTOCs were formed with dissociated GFP- C57BL/6 fetal thymic
lobes, following the protocol mentioned above, in a ratio of ~75,000 sorted
CD45+EpCAM+GFP+ cells with ~1,000,000 fetal cells per RTOC. Prior to engraftment under
the kidney capsule of an athymic nude mouse, the RTOCs were analyzed under a fluorescent
microscope to show the presence of GFP+ cells (Supplemental Figure 2). These RTOC were
then engrafted and allowed to grow for 3 weeks before the kidneys were removed and the
reaggregates were analyzed histologically. PanK+ FoxN1+ GFP+ cells were seen in the RTOCs
(Figure 19 and 20). RTOCs derived from bone marrow had more GFP+ TECs, indicated by
arrows in figure 19, whereas thymus derived RTOCs had a rarer GFP+ TEC population. This
shows that bone marrow and thymus derived CD45+ EpCAM+ cells can give rise to thymic
epithelium when placed in environment of a reaggregate.

Pan-K

FOXN1

GFP

Merge

Figure 19. Bone marrow derived reaggregate thymic organ cultures show that CD45+ EpCAM+
cells can give rise to PanK+ FoxN1+ thymic epithelial cells.

Figure 20. Thymus derived reaggregate thymic organ cultures show that CD45+ EpCAM+ cells
can give rise to PanK+ FoxN1+ thymic epithelial cells.
Further characterization of CD45+ EpCAM+ cells
Osada et al. 2013 previously demonstrated that a population of label retaining cells
characterized by Sca1 expression together with the integrin’s Alpha 6 and Beta 1, exhibited
characteristics of mesenchymal stem cells with the capacity to differentiate into multiple
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mesenchymal linages of mesenchymal stem cells (chondrogenesis, osteogenesis, adipogenesis)
as well as maintaining the capacity to differentiate into TECs in vivo. Using this phenotype,
Wong et al. defined thymic epithelial progenitor cells as Sca1+ alpha 6 (CD49f) hi. Taking these
findings together, we wanted to analyze the CD45+ EpCAM+ TEC population for known
epithelial stem cell markers. It was found to express a phenotype similar to that described for
TEC progenitors, namely CD49f+, CD29+ and Sca1+ (Figure 21). A CD45+, EpCAM+, MHCII
lo, Sca1+, CD29 hi, CD49f hi was found, that fits the description of a progenitor cell, an
immature cell (MHCII lo) that is also enriched for stem cell markers. Additionally, this potential
progenitor pool is found primarily in the CD45+ EpCAM+ population and is quite abundant
there (75.7%) compared to the other populations. This taken together with figure 15, which
shows the presence of a DEC205+ GFP+ cell in a medullary area further provides evidence that
this population may in fact be the elusive thymic epithelial progenitor cell population that has
eluded thymic epithelial scientists.

Figure 21. CD45+ EpCAM+ cells are enriched for the known thymic epithelial progenitor
markers CD29 and CD49f. These cells can be identified as CD45+ EpCAM+ MHCIIlo Sca1+
CD29hi CD49fhi.
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CD45+ EpCAM+ cells are not derived from cell fusion
Recently, it has been shown that cell fusion occurs after BMT [76-79]. To address if our
population is a result of cell fusion or more conventional origins, we can design an experiment
very similar to the one used in figure 9. We implanted fetal thymuses derived from Rosa26
mRFP (membrane bound red fluorescence protein) into the kidney capsules of Actin H2BGFP
mice. If cell fusion is causing these cells to appear we should see cells that express both GFP and
RFP along with CD45 and EpCAM. However, if cell fusion is not present we should not see the
co-expression of both RFP and GFP, in the CD45+ EpCAM+ and EpCAM+ populations. When
analyzing the results of this experiment through flow cytometry we see that there is no
coexpression of GFP and mRFP in either the CD45- EpCAM+ population, the CD45+ EpCAM+
population, or the CD45+ EpCAM- (Figure 22). We also analyzed CD45+ EpCAM- cells to see
if fusion was occurring in that population. However, this experiment has been completed once
and needs to be replicated.
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Figure 22. Cell fusion does not seem to give rise to either the CD45+ EpCAM+ population or the
EpCAM+ population. Arrows show how different subpopulations express mRFP and GFP.

Discussion
The identification of an abundant CD45+ EpCAM+ TEC subset suggests that thymic
epithelial biologists have been missing a significant portion of TECs when using the standard
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CD45 magnetic bead depletion approach. This could potentially explain the observed disparity
between histology results and flow analysis with respect to cTEC and mTECs as well as the
difficulty in identifying a true TEC progenitor/stem cell population. The presence of this
previously ignored incompletely characterized population of TECs requires more analysis to
determine its role in thymic development and if they truly contribute to the maintenance of
thymic epithelia. As opposed to the consensus among some immunologists (Nakagawa et al.), we
believe that this population is not comprised of thymic nurse cells (TNCs). This is because TNCs
are epithelial cells that internalize T-cells. However, when observing the sorted cells imaged in
Figures 3 and 4, the cells are not TNC complexes but individual CD45+ EpCAM+ cells. Another
possible explanation for these histology results could be epitope sharing, which might be caused
by the abundant T-cells that are tightly associated with TECs having its CD45 antigen sheared
off during thymic digestion and transferred to the TEC whilst undergoing crosstalk. Since there
is an even distribution of CD45/EpCAM on the surface of the CD45+ EpCAM+ cells in Figures
5 and 6 and that there is an abundance of antibody bound, this idea is plausible but highly
unlikely. It is shown that the double positive population has increased expression of both CD45
and EpCAM in the flow cytometric analysis in figures 5 and 6, showing this to be a true
population that is actually expressing both genes. To further validate this point, CD45+
EpCAM+ cells isolated from either the bone marrow or the thymus both have CD45 and
EpCAM mRNA present. However, when looking at the levels of RNA transcripts the double
positive population in relation to the single positive populations (CD45 or EpCAM) the
expression levels are not as high but reflects actual protein levels detected by flow cytometry.
This may suggest that the double positive population may be a transitioning from one population
to another. Furthermore, the presence of CD45+ EpCAM+ cells in the bone marrow show that
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this population may originate in the bone marrow and are then recruited to the thymus to give
rise to TECs, a theory supported by other literature positing that BM-derived CD45+ EpCAM+
cells can give rise to cells in other epithelial organs [70, 75, 77, 81]. The lack of an EpCAM
population in the bone marrow makes it difficult to compare EpCAM expression in that tissue,
even though the CD45+ EpCAM+ population has significantly higher EpCAM RNA transcripts
relative to CD45 only cells. These results look promising, however, it can still be argued that this
population may be contaminated with other cell populations during sorting. To remove this
possibility, a single cell qPCR must be conducted to ensure that only true singular CD45+
EpCAM+ cells are analyzed. The single cell nature is completely supported by the histology
showing strong surface co-expression at the protein level.
The presence of these CD45+ EpCAM+ cells in fetal development provides stronger
evidence that this is a true population, especially because these cells are found at very early
points in development when a low number of T-cells have colonized the thymus. These cells
may be a true progenitor population that give rise to TECs; to further validate this point more
time points must be analyzed in fetal development. Also, the fetal liver should be analyzed for
the presence of this population to see if these cells are contributing to TEC development prior to
the development of the BM. In future experiments, fetal liver must be isolated at E12.5-E15.5
and blood islands from E9.5-11.5 should also be analyzed for this population. This is because the
fetal liver acts as the location for hematopoietic cell development prior to the formation of bone
marrow. Further blood islands are the initial niches for hematopoietic stem cell development.
Our results show that cells originating from the periphery can give rise to thymic
epithelium (Figures 9-12). Some may argue that the bone marrow is not the origin of these cells
and that the GFP+ cells may originate from a different location, but this is hard to believe since
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these cells express a marker (CD45) that is specific to hematopoietic cells and that the bone
marrow is the site of hematopoietic cell development and contains the EpCAM+CD45+ subset.
Also, since the kidney is the location of blood filtration it is plausible to think that bone marrow
derived cells localized to the thymic grafts placed under the kidney capsule of Actin H2BGFP
mice. There is, however, a discrepancy in the frequency between our flow cytometry data and
our histology results. This can be attributed to the fact that the GFP fluorescence in the EpCAM+
CD45- population is low, but still positive. When the tissue was analyzed under a confocal
microscope there may have been photobleaching of the already weak GFP fluorescence. In
addition, it is difficult to say which population from the periphery is giving rise to the green
TECs that were seen from these experiments. When CD45+ EpCAM+ cells are specifically
selected from the bone marrow from Actin H2BGFP mice and placed in an RTOC system, they
give rise to GFP+ TECs (Figure 19). Furthermore, the capability of thymic derived CD45+
EpCAM+ GFP+ cells to give rise to TECs in an RTOC system shows that it is plausible to label
them as thymic epithelial progenitor cells (Figure 20). To definitively show that CD45+
EpCAM+ cells can give rise to TECs, bone marrow-derived cells from Actin H2BGFP should be
injected into irradiated C57BL6 mice, showing that the double positive cells are the source of the
results seen in figures 9-12.
When analyzing the histology data there is quite a large population that is not defined by
either TEC or T-cell markers. FSP-1 has been shown to maintain mTECs and are a significant
population in the thymic stroma [52]. We have shown for the first time that FSP-1 expressing
cells originate in the periphery and represent a significant population of the cells that enter from
the periphery (Figures 16, 17 and 18). When looking at FSP1 expression at weeks 3 and 6 FSP1+
cells make up a low amount of GFP+ cells, peaking at week 9 then decreasing at week 12. When
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looking at Figure 11 and 18 together, there is a concurrent increase in CD45+EpCAM+GFP+
cells and FSP1+GFP+ cells at week 9, which indicates that there may be a correlation between
CD45+EpCAM+ cells and FSP1+ cells, suggesting that CD45+EpCAM+ cells may give rise to a
large portion of FSP1+ cells. A plausible explanation may be that at some point between weeks 6
and 9 there may be a critical window where CD45+EpCAM+ recruitment from the periphery
peaks, possibly by the formation of proper vasculature. At week 12, this population may
decrease as the need for FSP1+ cells have diminished. The question still remains whether there is
a developmental link between FSP-1 expressing cells and TECs. It can be proposed that TECs
may become FSP-1 cells as the thymus involutes and undergoes epithelial mesenchymal
transition and that CD45+ EpCAM+ may be a transitory phase in this transition. However, it is a
very real possibility that FSP-1 cells can give rise to TECs through MET or that CD45+
EpCAM+ have the capability to give rise to FSP-1 or TECs irreversibly. To investigate these
possibilities a lineage tracing experiment has to be done in which a single CD45+ EpCAM+ cell
is injected directly into the thymus of a mouse, which is then analyzed to check what this cell has
become.
The thymic derived CD45+ EpCAM+ population does seem to be enriched in markers
that have been identified as key markers for the TEPC niche (Figure 21). Recently, several
studies have shown that DEC205 is a marker of a bipotent TEPC population [9, 65]. Figure 15
clearly shows a GFP+ cell that expresses DEC205 at both Week 9 and 12 after grafting,
indicating that a peripheral population is giving rise to thymic epithelium. Interestingly, at week
9, we can saw a cell that is expressing DEC205, GFP and UEA1, which could potentially be a
TEPC developing into an mTEC. This hypothesis is further supported by the fact that these cells
are found in an area that is largely devoid of DEC205 and can be classified as the medulla.
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Further, stage specific embryonic antigen 1 (SSEA1) will also be analyzed as it has been cited by
other researchers as another marker of TEPCs [65]. Although we seem to have analyzed several
markers for this niche, more analysis must be conducted to better define this population. The best
way to go about this is to either analyze for the presence of different mRNAs using an array for
stem cell markers or to analyze the RNA isolated using RNA-seq to elucidate more markers for
this population.
The implications of this finding can be wide ranging in the field of thymic development,
even if this CD45+ EpCAM+ population is not found to contain the progenitor cell of thymic
epithelia. When isolating thymic epithelial cells, the consensus procedure involves some sort of
CD45 depletion, which, according to our findings, is causing a loss of a significant portion of
EpCAM+ epithelia. Analysis of figure 3 shows that utilizing an alternative depletion method
enhances the CD45+ EpCAM+ population, but the total TEC ratio is not affected (4.22% vs
4.87%), suggesting that TECs are not being negatively affected by this alternative depletion
method. Furthermore, this double positive population is shown to be enriched in cells that show a
stem cell like characteristic, Sca1+, CD29+, CD49f+. We propose that CD45 depletion is
causing the loss of thymic epithelial progenitor cells and that may explain why identifying this
population has been so elusive.
In future experiments, we must improve our depletion method to ensure that this
population is not negatively affected. One alternative depletion method we can use is Thy1
depletion, which is another pan-hematopoietic marker that should diminish all T-cells (CD4,
CD8, CD25, CD44), dendritic cells and macrophages (CD11b/c) with CD19 to rule out B-cells.
Once that is done we can conduct single cell qPCR from both thymus and bone marrow using
primers for CD45 and various epithelial genes to ensure that this population is both a
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hematopoietic and epithelial in nature beyond a shadow of a doubt. This experiment will rule out
the idea of epitope sharing and will then provide more lines of evidence that this is a true
population in the thymus. We have shown that these cells can give rise to TECs (FoxN1+
PanK+), but we have not shown which populations of TECs they contribute to. In the future will
analyze these cells in both the RTOC system and organ transplant model for mTEC and cTEC
specific markers.
In previous studies, this CD45+ EpCAM+ population has been shown to be recruited
under stressful scenarios. Bratincsák et al. and Wong et al. 2009, have shown that when the
uterus and the lung, respectively, are stressed CD45+ EpCAM+ cells can come to those specific
organs and give rise to the respective epithelial cells. To test if the recruitment of the bone
marrow derived cells is a result of stress, C57BL6 should be injected with dexamethasone, a
compound that will specifically damage the thymus, and their thymuses will be analyzed at 3, 6,
9 and 12 days post injection to track the levels of CD45+ EpCAM+ cells and EpCAM+ cells.
The hypothesis is that if CD45+ EpCAM+ cells do indeed give rise to TECs then in the initial
days after injection we should see an increase in the double positive population, then a gradual
decrease with time, whereas the TEC population will start out low but should increase with time.
Recently, it has been shown that cell fusion has been shown to occur after BMT [76-79].
To address this issue, we designed an experiment in which we implanted fetal thymuses derived
from Rosa26 mRFP (membrane bound red fluorescent protein) into the kidney capsules of Actin
H2BGFP mice. Our results show that cell fusion is not contributing to the generation of CD45+
EpCAM+ population. However, previous stated that BMT leads to cell fusion; while this model
disputes cell fusion we still have to see if BMT gives rise to fused cells.
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Overall, it seems that CD45+ EpCAM+ cells originate in the bone marrow, migrate to the
thymus, and contribute to thymic stromal compartments. BM-derived CD45+ EpCAM+ cells
migrate to the thymus, where they can give rise to EpCAM expressing TECs and FSP-1
expressing fibroblasts. However, the link between these putative BM-derived EpCAM
expressing cells and BM-derived FSP-1 expressing cells needs to be elucidated. It is possible that
these cells arise independently or that there is a causal link between FSP-1+ cells and EpCAM+
cells (either through epithelial-mesenchyme transition or mesenchyme-epithelial transition).
Furthermore, more work has to be done to see if these FSP-1 expressing cells also maintain
mTECs through FGF7 production [52] (Figure 23).
Overall, these results can be paradigm shifting for the field of thymic development and
immunology as a whole, the implications of which can be wide ranging. At the very least, this
study shows that TEC biologists have been losing quite a number of TECs by using a CD45
depletion strategy. This work for the first time shows that a population derived from the
periphery can give rise to thymic stromal components, TECs, and to a larger extent FSP-1
expressing fibroblasts, the origin of which has been under much scrutiny. Furthermore, they
seem to arise from true transdifferentiation and not cell fusion. If these cells can be verified to be
in humans they can be used as a therapeutic to treat individuals that suffer from a weakened
immune system, or in individuals that undergo cytoablative therapy.
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Figure 23. Schematic representation of the contributions of CD45+ EpCAM+ cells to thymic stroma compartments. BM-derived
CD45+ EpCAM+ cells migrate to the thymus where they can give rise to EpCAM expressing TECs and FSP-1 expressing fibroblasts.
It is possible that these cells arise independently or that there is a causal link between FSP-1+ cells and EpCAM+ cells (either through
epithelial-mesenchyme transition or mesenchyme-epithelial transition). Furthermore, more work has to be done to see if these FSP-1
expressing cells also maintain mTECs through FGF7 production.
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Supplemental Figures

Supplemental Figure 1. A peripheral population can give rise to potential thymic epithelial progenitors.

RTOC before implant

Supplemental Figure 2. Reaggregates derived from Actin H2BGFP bone marrow cells were analyzed under a fluorescence microscope
for the presence of GFP prior to implantation under the kidney capsule.
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